Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 59, Issue 10, Pages 1147-1158
Publisher
Wiley
Online
2020-08-28
DOI
10.1002/mc.23245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Combination of MEK inhibitor with Immunomodulatory Antibodies Targeting PD-1 and PD-L1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer
- (2019) Jong Woo Lee et al. Journal of Thoracic Oncology
- MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer
- (2019) Ofra Novoplansky et al. INTERNATIONAL JOURNAL OF CANCER
- BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC
- (2018) Brandon Leonard et al. CANCER RESEARCH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
- (2018) Jun Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1
- (2018) Junyu Cao et al. Molecular Oncology
- Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma
- (2017) Jennifer D. Moy et al. EUROPEAN JOURNAL OF CANCER
- Osteopontin at the Crossroads of Inflammation and Tumor Progression
- (2017) Luigi Mario Castello et al. MEDIATORS OF INFLAMMATION
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
- (2017) Yuanyuan Lu et al. NATURE MEDICINE
- Osteopontin -- a promising biomarker for cancer therapy
- (2017) Ran Wei et al. Journal of Cancer
- The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer
- (2017) Joanne B. Weidhaas et al. JAMA Oncology
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells
- (2016) Guoke Liu et al. CANCER LETTERS
- HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models
- (2016) Dongsheng Wang et al. CLINICAL CANCER RESEARCH
- Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
- (2016) P. Bossi et al. CLINICAL CANCER RESEARCH
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- KRAS-related proteins in pancreatic cancer
- (2016) Karen M. Mann et al. PHARMACOLOGY & THERAPEUTICS
- CTLA-4+Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
- (2015) Hyun-Bae Jie et al. CANCER RESEARCH
- Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer
- (2015) Y. Sharon et al. CANCER RESEARCH
- Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin
- (2015) Tommy Hui et al. MATRIX BIOLOGY
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
- (2014) C. H. Chung et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Osteopontin Knockdown Inhibits av,�3Integrin-Induced Cell Migration and Invasion and Promotes Apoptosis of Breast Cancer Cells by Inducing Autophagy and Inactivating the PI3K/Akt/mTOR Pathway
- (2014) Hao Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- KRAS: feeding pancreatic cancer proliferation
- (2014) Kirsten L. Bryant et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
- (2013) R. M. Srivastava et al. CLINICAL CANCER RESEARCH
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Osteopontin Promotes Mesenchymal Stem Cell Migration and Lessens Cell Stiffness via Integrin β1, FAK, and ERK Pathways
- (2012) Chengyu Zou et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling
- (2011) Raquel Urtasun et al. HEPATOLOGY
- Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression
- (2011) T. M. Tilli et al. MOLECULAR CANCER RESEARCH
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma
- (2011) Chien-Hua Peng et al. PLoS One
- Immunotherapy for head and neck cancer
- (2010) Anna-Maria De Costa et al. ANTI-CANCER DRUGS
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
- (2009) Cherry L Estilo et al. BMC CANCER
- Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells
- (2009) R. Behera et al. CARCINOGENESIS
- Osteopontin increases migration and MMP-9 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells
- (2009) Ying-Ju Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies
- (2008) Jan. B. Vermorken et al. CANCER
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulated molecular networks in head and neck carcinogenesis
- (2008) Alfredo A. Molinolo et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now